Participants in an alcohol use disorder trial spontaneously reduced cigarette and cannabis use without being prompted, and cannabis reduction in early treatment was inversely associated with alcohol consumption.
Addiction medicine clinicians, AUD researchers, and clinicians treating patients with polysubstance use
What the researchers found
Cigarette use declined significantly over 12 weeks (p=.002); cannabis decreased early (p=.006) then rebounded (p=.03); early cannabis reduction was negatively associated with drinks per drinking day, suggesting a compensatory relationship.
Why it matters
The finding that treating one substance problem can ripple across others challenges the single-substance treatment model — and suggests comprehensive substance use screening should be standard in addiction trials.
The numbers in context
102 participants (61M/41F); significant cigarette reduction (p=.002); cannabis decrease early (p=.006) then increase (p=.03); cannabis changes inversely associated with drinks/drinking day (p<.05).
How the study worked
Secondary analysis of a 12-week RCT of ibudilast for AUD (N=102), examining unprompted changes in cigarette and cannabis use and their associations with drinking outcomes.
What this study cannot tell us
Secondary analysis not powered for these outcomes; relatively small sample; co-occurring use patterns make it difficult to isolate individual substance effects; ibudilast effects on other substances unknown.
How to read the evidence
Secondary analysis of a well-designed RCT with appropriate statistical methods, but limited by small sample and post-hoc nature.
When this study was published
Published in 2026, contributing to the growing evidence for comprehensive substance use assessment in addiction treatment.
The bigger picture
The early cannabis reduction followed by rebound could represent a substitution pattern — patients may initially reduce all substances but then return to cannabis as a coping alternative to alcohol.
Questions still open
- Is the cannabis rebound a substitution effect? Would targeting all three substances simultaneously improve outcomes? Should AUD trials routinely track cannabis and tobacco use?
Common questions
Does treating alcohol addiction affect other substance use?
Is cannabis use related to alcohol consumption?
Read the original research
Reductions in cigarette and cannabis use during a randomized clinical trial for alcohol use disorder.
Alcohol and alcoholism (Oxford, Oxfordshire), 61(2)
Citation
Belnap, Malia A; McManus, Kaitlin R; Kirsch, Dylan E; Grodin, Erica N; Ray, Lara A. (2026). Reductions in cigarette and cannabis use during a randomized clinical trial for alcohol use disorder.. Alcohol and alcoholism (Oxford, Oxfordshire), 61(2). https://doi.org/10.1093/alcalc/agag006
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk
- Blunts vs Joints vs Spliffs: What's Actually Different